Lantheus Holdings (LNTH) Revenue (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Revenue of $377.3 million for Q1 2026, up 1.23% year-over-year from $372.8 million in Q1 2025, and down 7.24% quarter-over-quarter from $406.8 million in Q4 2025.
Lantheus Holdings (LNTH) Revenue (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Revenue for 13 consecutive years, with $377.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue rose 1.23% year-over-year to $377.3 million; the TTM figure through Mar 2026 stood at $1.5 billion (up 0.62% YoY), while the FY2025 annual figure was $1.5 billion, up 0.5% from the prior year.
- Revenue declined to $377.3 million in Q1 2026 per LNTH's latest filing, from $406.8 million in the prior quarter.
- Across five years, Revenue topped out at $406.8 million in Q4 2025 and bottomed at $15.0 million in Q4 2023.
- Historically, Revenue has averaged $314.4 million across 5 years, with a median of $370.0 million in 2024.
- Annual changes were most pronounced in 2023 — Revenue tumbled 94.3% — and 2024, when it soared 2507.4%.
- Lantheus Holdings' Revenue stood at $263.2 million in 2022, then sank by 94.3% to $15.0 million in 2023, then jumped by 2507.4% to $391.1 million in 2024, then gained by 4.01% to $406.8 million in 2025, then retreated by 7.24% to $377.3 million in 2026.
- Business Quant data shows LNTH's Revenue at $377.3 million in Q1 2026, $406.8 million in Q4 2025, and $384.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.95 Bn | 241.86 Mn | 388.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 388.18 Mn |
| Mar 31, 2026 | 377.33 Mn |
| Dec 31, 2025 | 406.79 Mn |
| Sep 30, 2025 | 384.01 Mn |
| Jun 30, 2025 | 378.05 Mn |
| Mar 31, 2025 | 372.76 Mn |
| Dec 31, 2024 | 391.11 Mn |
| Sep 30, 2024 | 378.73 Mn |
| Jun 30, 2024 | 394.09 Mn |
| Mar 31, 2024 | 369.98 Mn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2023 | 319.95 Mn |
| Jun 30, 2023 | 321.70 Mn |
| Mar 31, 2023 | 300.78 Mn |
| Dec 31, 2022 | 263.17 Mn |
| Sep 30, 2022 | 239.29 Mn |
| Jun 30, 2022 | 223.72 Mn |
| Mar 31, 2022 | 208.88 Mn |
| Dec 31, 2021 | 129.56 Mn |
| Sep 30, 2021 | 102.07 Mn |